Genmab reported 140.33B in Market Capitalization this January of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agios Pharmaceuticals AGIO:US $ 2.72B 0.67B
Alexion Pharmaceuticals ALXN:US $ 33.78B 0.39B
Almirall ALM:SM 2.47B 175M
Amarin AMRN:US 2.01B 0.28B
Amgen AMGN:US $ 120.75B 19.29B
Argen X Bv ARGX:BB 13.22B 224.12M
AstraZeneca AZN:LN 138.77B 24.78B
Bayer BAYN:GR 46.18B 4.3B
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Bluebird Bio BLUE:US $ 1.29B 0.87B
Exelixis EXEL:US $ 6.66B 0.95B
Fresenius Medical Care FME:GR 17.83B 2.69B
Galapagos GLPG:NA 2.96B 872.42M
Genmab GEN:DC 184.51B 16.13B
GlaxoSmithKline GSK:LN 70.63B 794.04M
GN Store Nord GN:DC 61.5B 14.19B
GRIFOLS GRF:SM 13.6B 337.76M
H. Lundbeck A/S LUN:DC 34.74B 4.99B
Hikma Pharmaceutical HIK:LN 5.66B 142.14M
Immunogen IMGN:US $ 1.18B 0.14B
Insmed INSM:US $ 3.26B 0.04B
Lonza Group LONN:SW 48.84B 6.48B
Merck MRK:GR 24.25B 3.35B
Novartis NOVN:VX 187.04B 20.99B
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Sanofi SAN:FP 104.97B 6.43B
Seattle Genetics SGEN:US $ 30.89B 2.24B
UCB UCB:BB 17.15B 715.78M
William Demant Holding WDH:DC 84.77B 26.85B